Letter to the editor
Robert G NewmanBaron Edmond de Rothschild Chemical, Dependency Institute of Beth Israel Medical Center, New York, NY, USAIn response to "Privacy protection for patients with substance use problems", there is indeed a compelling reason to worry about loosening of the Federal...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2012-03-01
|
| Series: | Substance Abuse and Rehabilitation |
| Online Access: | http://www.dovepress.com/-letter-to-the-editor--a9485 |
| id |
doaj-70f1f9327ac945039ab3b10bef307218 |
|---|---|
| record_format |
Article |
| spelling |
doaj-70f1f9327ac945039ab3b10bef3072182020-11-25T02:15:43ZengDove Medical PressSubstance Abuse and Rehabilitation1179-84672012-03-012012Issue 1910Letter to the editorNewman RGRobert G NewmanBaron Edmond de Rothschild Chemical, Dependency Institute of Beth Israel Medical Center, New York, NY, USAIn response to "Privacy protection for patients with substance use problems", there is indeed a compelling reason to worry about loosening of the Federal confidentiality regulation, 42 CFR Part 2, which requires special protection for patient information maintained by addiction treatment facilities. This concern is not so much based on fear of misuse and/or unauthorized further disclosure by the recipient of such information.http://www.dovepress.com/-letter-to-the-editor--a9485 |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
Newman RG |
| spellingShingle |
Newman RG Letter to the editor Substance Abuse and Rehabilitation |
| author_facet |
Newman RG |
| author_sort |
Newman RG |
| title |
Letter to the editor |
| title_short |
Letter to the editor |
| title_full |
Letter to the editor |
| title_fullStr |
Letter to the editor |
| title_full_unstemmed |
Letter to the editor |
| title_sort |
letter to the editor |
| publisher |
Dove Medical Press |
| series |
Substance Abuse and Rehabilitation |
| issn |
1179-8467 |
| publishDate |
2012-03-01 |
| description |
Robert G NewmanBaron Edmond de Rothschild Chemical, Dependency Institute of Beth Israel Medical Center, New York, NY, USAIn response to "Privacy protection for patients with substance use problems", there is indeed a compelling reason to worry about loosening of the Federal confidentiality regulation, 42 CFR Part 2, which requires special protection for patient information maintained by addiction treatment facilities. This concern is not so much based on fear of misuse and/or unauthorized further disclosure by the recipient of such information. |
| url |
http://www.dovepress.com/-letter-to-the-editor--a9485 |
| work_keys_str_mv |
AT newmanrg lettertotheeditor |
| _version_ |
1724894229227896832 |